Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | ATM | Q13315 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | TNKS | O95271 | 1/20 | 0.37 |
| ▸ | CDY1; CDY1B | Q9Y6F8 | 2/20 | 0.36 |
| ▸ | CBX7 | O95931 | 1/20 | 0.36 |
| ▸ | CDYL2 | Q8N8U2 | 1/20 | 0.36 |
| ▸ | CDYL | Q9Y232 | 1/20 | 0.36 |
| ▸ | USP14 | P54578 | 2/20 | 0.35 |
| ▸ | PTGER4 | P35408 | 1/20 | 0.35 |
| ▸ | ENPP3 | O14638 | 1/20 | 0.35 |
| ▸ | RORC | P51449 | 3/20 | 0.35 |
| ▸ | RPS6KB1 | P23443 | 2/20 | 0.34 |
| ▸ | CA1 | P00915 | 2/20 | 0.34 |
| ▸ | CA2 | P00918 | 2/20 | 0.34 |
| ▸ | G6PD | P11413 | 1/20 | 0.34 |
| ▸ | GSK3B | P49841 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17115470 | 1.00 | KDM4E (0.38) | KDM4EALDH1A1ATML3MBTL1TNKS | |
| SCHEMBL18010697 | 1.00 | KDM4E (0.38) | KDM4EALDH1A1ATML3MBTL1TNKS | |
| SCHEMBL18010698 | 1.00 | KDM4E (0.38) | KDM4EALDH1A1ATML3MBTL1TNKS | |
| SCHEMBL17102407 | 1.00 | KDM4E (0.38) | KDM4EALDH1A1ATML3MBTL1TNKS | |
| SCHEMBL17102413 | 1.00 | KDM4E (0.38) | KDM4EALDH1A1ATML3MBTL1TNKS | |
| SCHEMBL17705058 | 0.97 | TNKS (0.39) | KDM4EALDH1A1ATML3MBTL1TNKS | |
| SCHEMBL17102397 | 0.97 | TNKS (0.39) | KDM4EALDH1A1ATML3MBTL1TNKS | |
| SCHEMBL17706348 | 0.97 | KDM4E (0.40) | KDM4EALDH1A1ATML3MBTL1TNKS | |
| SCHEMBL18031020 | 0.96 | CDY1; CDY1B (0.36) | KDM4EALDH1A1ATML3MBTL1TNKS | |
| SCHEMBL18030948 | 0.95 | TNKS (0.40) | KDM4EALDH1A1ATML3MBTL1TNKS |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3061759-B1 | NITRILE SUBSTITUTED DIBENZOFURANS | IDEMITSU KOSAN CO (JP) | 2019-12-25 | — | — | EP | disclosed |
| US-10193080-B2 | Condensed cyclic compound and organic light-emitting device including the same | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2019-01-29 | — | — | US | disclosed |
| EP-3061759-A1 | NITRILE SUBSTITUTED DIBENZOFURANS | Idemitsu Kosan Co., Ltd (JP) | 2016-08-31 | — | — | EP | disclosed |
| US-20160248026-A1 | NITRILE SUBSTITUTED DIBENZOFURANS | IDEMITSU KOSAN CO., LTD. (JP) | 2016-08-25 | — | — | US | disclosed |
| US-20160118601-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG ELECTRONICS CO., LTD. (KR) | 2016-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160118601-A1 | CONDENSED CYCLIC COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | CRY1, CCNE2, CRY2 | KDM4E 2083/4885ALDH1A1 250/4885ATM 1137/4885 |
| US-20160248026-A1 | NITRILE SUBSTITUTED DIBENZOFURANS | DBF4, NXF1, NCF1 | KDM4E 1878/4885ALDH1A1 1679/4885ATM 4689/4885 |
| US-10193080-B2 | Condensed cyclic compound and organic light-emitting device including the same | CRY1, CCNE2, CRY2 | KDM4E 2083/4885ALDH1A1 250/4885ATM 1137/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.